Belite Bio, Inc - BLTE
About Gravity Analytica
Recent News
- 09.27.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.27.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.12.2025 - Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
- 09.12.2025 - Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
- 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.08.2025 - Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
- 09.08.2025 - Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
- 09.05.2025 - Cantor Global Healthcare Conference
- 09.05.2025 - Cantor Global Healthcare Conference